2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: Executive summary
2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: Executive summary
复制标题
DOI：
10.1016/j.hrthm.2017.07.009
复制
发表时间：
2017-10-01
期刊：
影响因子：
5.5
通讯作者：
Yamane, Teiichi
中科院分区：
文献类型：
--
作者：
Calkins, Hugh;Hindricks, Gerhard;Yamane, Teiichi
在过去的三十年里，房颤（AF）的导管和手术消融已从研究性手术发展成为目前AF患者的有效治疗选择。使用标准、微创或混合技术的AF手术消融可在世界上大多数主要医院使用。AF的导管消融术甚至更广泛地可用，并且现在是最常进行的导管消融术。2007年，心律协会（HRS）、欧洲心律协会（EHRA）和欧洲心律失常协会（ECAS）共同制定了关于导管和外科房颤消融的初步共识声明[1]。2007年的文件也是与胸外科医师协会（STS）和美国心脏病学会（ACC）合作制定的。2012年对导管和外科房颤消融的共识声明进行了重写，以反映在此期间发生的房颤消融的许多进展[2]。随着大量的研究工作集中在房颤的机制、结局和治疗上，房颤消融的工具、技术和结局的进步速度不断加快。因此，HRS发起了重写和更新本共识声明的工作。本文件反映了AF的全球重要性以及AF消融的全球性能，是HRS、EHRA、ECAS、亚太心律学会（APHRS）和拉丁美洲心脏刺激和电生理学会（Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología [SOLAECE]）联合合作的结果。本2017年共识声明的目的是提供房颤导管和手术消融领域的最新综述，并报告由这五个国际学会召集的写作小组的研究结果。写作小组负责定义房颤消融术的适应症、技术和结局。本文件包括与房颤消融领域临床试验设计和结局报告相关的建议，包括与本主题相关的定义。撰写小组由代表11个组织的60名专家组成：HRS、EHRA、ECAS、APHRS、SOLAECE、STS、ACC、美国心脏协会（AHA）、加拿大心律学会（CHRS）、日本心律学会（JHRS）和巴西心律失常学会（Sociedade Brasileira de Arritarian Cardíacas [SOBRAC]）。所有
During the past three decades, catheter and surgical ablation of atrial fibrillation (AF) have evolved from investigational procedures to their current role as effective treatment options for patients with AF. Surgical ablation of AF, using either standard, minimally invasive, or hybrid techniques, is available in most major hospitals throughout the world. Catheter ablation of AF is even more widely available, and is now the most commonly performed catheter ablation procedure. In 2007, an initial Consensus Statement on Catheter and Surgical AF Ablation was developed as a joint effort of the Heart Rhythm Society (HRS), the European Heart Rhythm Association (EHRA), and the European Cardiac Arrhythmia Society (ECAS)[1]. The 2007 document was also developed in collaboration with the Society of Thoracic Surgeons (STS) and the American College of Cardiology (ACC). This Consensus Statement on Catheter and Surgical AF Ablation was rewritten in 2012 to reflect the many advances in AF ablation that had occurred in the interim [2]. The rate of advancement in the tools, techniques, and outcomes of AF ablation continue to increase as enormous research efforts are focused on the mechanisms, outcomes, and treatment of AF. For this reason, the HRS initiated an effort to rewrite and update this Consensus Statement. Reflecting both the worldwide importance of AF, as well as the worldwide performance of AF ablation, this document is the result of a joint partnership between the HRS, EHRA, ECAS, the Asia Pacific Heart Rhythm Society (APHRS), and the Latin American Society of Cardiac Stimulation and Electrophysiology (Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología [SOLAECE]). The purpose of this 2017 Consensus Statement is to provide a state-of-the-art review of the field of catheter and surgical ablation of AF and to report the findings of a writing group, convened by these five international societies. The writing group is charged with defining the indications, techniques, and outcomes of AF ablation procedures. Included within this document are recommendations pertinent to the design of clinical trials in the field of AF ablation and the reporting of outcomes, including definitions relevant to this topic. The writing group is composed of 60 experts representing 11 organizations: HRS, EHRA, ECAS, APHRS, SOLAECE, STS, ACC, American Heart Association (AHA), Canadian Heart Rhythm Society (CHRS), Japanese Heart Rhythm Society (JHRS), and Brazilian Society of Cardiac Arrhythmias (Sociedade Brasileira de Arritmias Cardíacas [SOBRAC]). All